TNYA
Tenaya TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
TNYA Profile
Tenaya Therapeutics, Inc.
A clinical-stage biotech company that develops gene therapies for rare genetic disorders
Biological Technology
--
07/30/2021
NASDAQ Stock Exchange
97
12-31
Common stock
171 Oyster Point Boulevard, 5th Floor, South San Francisco, CA 94080
--
Tenaya Therapeutics, Inc., was incorporated in Delaware in August 2016. The company is a preclinical stage biotechnology company focused on discovering, developing and delivering treatments for the underlying drivers of heart disease. The company is advancing product candidates from three distinct but interrelated product platforms: gene therapy, cell regeneration and precision medicine.
